NEWRON PHARMACEUTICALS SPA (NP5.DE) Stock Cash Flow
Europe - FRA:NP5 - IT0004147952 - Common Stock
16.32 EUR
-0.3 (-1.81%)
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 21.39M | -16.20M | -17.47M | -14.88M | -19.62M | |||
| Depreciation Amortization | 192.00K | 201.00K | 202.00K | 209.00K | 219.00K | |||
| Income Taxes - Deferred | null | null | null | null | null | |||
| Accounts Payable And Accrued Liabilities | undefined | undefined | undefined | undefined | undefined | |||
| Change In Working Capital | -39.60M | 351.00K | 702.00K | -1.06M | 3.19M | |||
| Interest Paid | 1.90M | 1.20M | 1.23M | 869.00K | 606.00K | |||
| Taxes Paid | null | null | null | null | null | |||
| Other non cash items | 400.00K | 5.51M | 5.48M | 4.29M | 619.00K | |||
| OPERATING CASH FLOW | -17.61M | -10.14M | -11.09M | -11.45M | -15.59M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -13.00K | -11.00K | -18.00K | -20.00K | -35.00K | |||
| Other Investing Activity | 3.17M | 3.26M | -299.00K | 8.44M | -581.00K | |||
| INVESTING CASH FLOW | 3.16M | 3.25M | -317.00K | 8.42M | -616.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -193.00K | -192.00K | -186.00K | 14.83M | 7.37M | |||
| Stock Issued/Repurchased | 15.41M | null | null | null | null | |||
| Dividend Paid | null | null | null | null | null | |||
| Other Financing Activity | -170.00K | null | null | null | null | |||
| FINANCING CASH FLOW | 15.05M | -192.00K | -186.00K | 14.83M | 7.37M | |||
| Exchange Rate Effect | null | null | null | null | null | |||
| CHANGE IN CASH | 595.00K | -7.09M | -11.60M | 11.81M | -8.84M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -17.61M | -10.14M | -11.09M | -11.45M | -15.59M | |||
| Capital Expenditure | -13.00K | -11.00K | -18.00K | -20.00K | -35.00K | |||
| FREE CASH FLOW | -17.63M | -10.15M | -11.11M | -11.46M | -15.62M | |||
All data in EUR